New pill shows promise for severe eczema in early trial
NCT ID NCT06996912
First seen Jan 07, 2026 · Last updated May 02, 2026 · Updated 17 times
Summary
This study tests an experimental tablet called HSK44459 in 150 adults with moderate-to-severe atopic dermatitis (eczema). The goal is to see if the drug can reduce skin redness, itching, and rash over 12 weeks compared to a placebo. Participants must have had eczema for at least a year and have significant skin involvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Dermatology Hospital of Shandong First Medical University
Jinan, Shandong, 250022, China
Conditions
Explore the condition pages connected to this study.